These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14290773)

  • 1. [CONTRIBUTION ON THE PHARMACEUTICAL CHEMISTRY OF CARISOPRODOL].
    BRIEVA AJ; ASTE OE; KUHN OS
    An Real Acad Farm; 1965; 31():8-29. PubMed ID: 14290773
    [No Abstract]   [Full Text] [Related]  

  • 2. NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 2000 Aug; (56):1-G14. PubMed ID: 11986679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abuse potential of carisoprodol: a retrospective review of Idaho Medicaid pharmacy and medical claims data.
    Owens C; Pugmire B; Salness T; Culbertson V; Force R; Cady P; Steiner J
    Clin Ther; 2007 Oct; 29(10):2222-5. PubMed ID: 18042478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of glucosamine and carisoprodol in pharmaceutical formulations by LC with pre-column derivatization and UV detection.
    Hadad GM; Abdel-Salam RA; Emara S
    J Chromatogr Sci; 2012 Apr; 50(4):307-15. PubMed ID: 22362883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [CONTRIBUTION TO METHODS OF EXAMINATION OF PHARMACEUTICAL PREPARATIONS. 8. DETERMINATION OF THE CONTENT OF THE CONSTITUENTS OF PHARMACEUTICAL PREPARATIONS WITH BARBITURIC ACID DERIVATIVES].
    BERAL H; DUMITRESCU E; CALAFETEANU IJ; GRINTESCU P; STOICESCU V
    Pharm Zentralhalle Dtschl; 1964; 103():331-41. PubMed ID: 14235087
    [No Abstract]   [Full Text] [Related]  

  • 6. Quantitation of Carisoprodol and Meprobamate in Urine and Plasma Using Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS).
    Slawson MH; Johnson-Davis KL
    Methods Mol Biol; 2016; 1383():105-14. PubMed ID: 26660179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [STATISTICAL STUDIES ON PHARMACEUTICAL SUSPENSIONS. 6. A CONTRIBUTION TO STABILITY DETERMINATION].
    ZACEK H
    Pharmazie; 1963 Nov; 18():766-70. PubMed ID: 14206116
    [No Abstract]   [Full Text] [Related]  

  • 8. FTIR assay method for UV inactive drug carisoprodol and identification of degradants by RP-HPLC and ESI-MS.
    Acharya PC; Vasi R; Suares D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Sep; 1029-1030():16-21. PubMed ID: 27398631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CONTRIBUTION ON THE MICROCHEMICAL TEST FOR CROTYLBARBITAL].
    PREUSSLER M
    Pharm Zentralhalle Dtschl; 1964; 103():409-11. PubMed ID: 14318309
    [No Abstract]   [Full Text] [Related]  

  • 10. [CONTRIBUTION TO THE CHEMISTRY OF THE ALKALOID ROTUNDIN FROM STEPHANIA ROTUNDA].
    DANGHANHKH OI
    Pharm Zentralhalle Dtschl; 1964; 103():99-108. PubMed ID: 14218735
    [No Abstract]   [Full Text] [Related]  

  • 11. [CONTRIBUTION TO THE DETERMINATION OF ANTIMONY (3) BY A POLARIMETRIC METHOD].
    PATRIARCHE G; MARICQ L
    J Pharm Belg; 1964; 19():477-80. PubMed ID: 14266538
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure of the metabolite of carisoprodol, hydroxycarisoprodol.
    Edelson J; Schlosser A; Douglas JF
    Biochem Pharmacol; 1965 May; 14(5):901-2. PubMed ID: 5840739
    [No Abstract]   [Full Text] [Related]  

  • 13. [CONTRIBUTION TO THE PROCESSING OF ELROLAN].
    HAEDICKE M
    Pharm Prax; 1963; 25():109. PubMed ID: 14050385
    [No Abstract]   [Full Text] [Related]  

  • 14. [CONTRIBUTION TO THE DETERMINATION OF ERYTHROMYCIN].
    WACHSMUTH H; VANKOECKHOVEN L
    J Pharm Belg; 1963; 18():581-5. PubMed ID: 14096757
    [No Abstract]   [Full Text] [Related]  

  • 15. [Contribution to the study of the Karl Fischer method for water determination].
    PIERAT F; MEIER G; BRIEVA A
    An Real Acad Farm; 1962 Dec; 28():297-309. PubMed ID: 13943392
    [No Abstract]   [Full Text] [Related]  

  • 16. [BORDER AREAS BETWEEN PHARMACY AND FOOD CHEMISTRY].
    EISENBRAND J
    Mitt Dtsch Pharm Ges Pharm Ges DDR; 1963 Dec; 33():209-22. PubMed ID: 14208821
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution to the microscopic determination of particle size].
    TAWASHI R; SPEISER P
    Pharm Acta Helv; 1961 Jun; 36():397-411. PubMed ID: 13775540
    [No Abstract]   [Full Text] [Related]  

  • 18. [CONTRIBUTION TO THE DETERMINATION OF LEVARTERENOL IN INJECTION SOLUTIONS].
    KAPETANIDIS I; MIRIMANOFF A
    Pharm Acta Helv; 1964 Feb; 39():119-26. PubMed ID: 14224304
    [No Abstract]   [Full Text] [Related]  

  • 19. PHYSICAL chemistry in pharmacy.
    Nature; 1948 Nov; 162(4124):789. PubMed ID: 18121585
    [No Abstract]   [Full Text] [Related]  

  • 20. [RADIOISOTOPES IN PHARMACEUTICAL TECHNOLOGY].
    SARSUNOVA M
    Cesk Farm; 1964 Nov; 13():470-3. PubMed ID: 14267759
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.